Vymada Tablet (Sacubitril + Valsartan)

Rating:
100% of 100

Vymada Tablets (Sacubitril + Valsartan) are a mixed medication used to treat cardiovascular breakdown. It lessens the gamble of hospitalization and demise due to enduring (constant) cardiovascular breakdown. Entresto is another brand name for Sacubitril + Valsartan.

Read More

Introduction of Vymada Tablet (Sacubitril + Valsartan)

Vymada tablet is a combination medication that contains two active ingredients, Sacubitril and Valsartan. It is used to treat heart failure with reduced ejection fraction (HFrEF) in adults. This medication works by relaxing blood vessels and improving the heart's ability to pump blood. It is also sold under the brand name Entresto. It comes in HEART & BLOOD PRESSURE category.

Mechanism of Action

Vymada contains two active ingredients, Sacubitril and Valsartan. Sacubitril works by inhibiting neprilysin, an enzyme responsible for breaking down various peptides, including natriuretic peptides. This inhibition leads to an increase in the levels of natriuretic peptides, which promote vasodilation and decrease blood pressure. Valsartan works by blocking the action of angiotensin II, a hormone that causes vasoconstriction and increases blood pressure. The combined action of these two drugs results in vasodilation and decreased blood pressure, which helps to improve the symptoms of heart failure. Vymada Tablet Company is Novartis Ltd, India.

Dosage

The recommended starting dose of Vymada is 49 + 51 mg (Sacubitril + Valsartan) twice daily. The dosage may be increased to a maximum of 97/103 mg (Sacubitril/Valsartan) twice daily, depending on the patient's tolerance and response to the medication. The dosage should be titrated gradually, with at least a two-week interval between dose increases. You can check Vymada Tablet Prices on our website - 1mgstore.com your most reliable pharmacy.

There are several benefits to using Entresto

Improved Symptoms: Vymada Tablet can improve the symptoms of heart failure, such as shortness of breath, fatigue, and swelling in the ankles and feet, which can greatly improve the quality of life for patients.

Reduced Risk of Hospitalization: Vymada Tablet has been shown to reduce the risk of hospitalization due to heart failure in patients with HFrEF.

Lowered Blood Pressure: Valsartan, one of the active ingredients in Vymada Tablet, is also used to lower high blood pressure (hypertension) in adults.

Improved Survival: Vymada Tablet has been shown to improve survival in patients with HFrEF.

Post-Myocardial Infarction: Vymada Tablet is also used in adult patients who have had a heart attack and have signs of heart failure or have a reduced ejection fraction.

Fewer Adverse Effects: Vymada Tablet has been shown to have fewer adverse effects compared to other heart failure medications.

Sacubitril and Valsartan Combination:

The combination of sacubitril and valsartan is a medication used to treat heart failure with reduced ejection fraction. Sacubitril is a neprilysin inhibitor that enhances the levels of beneficial peptides in the heart, while valsartan is an angiotensin receptor blocker (ARB) that helps relax blood vessels and lower blood pressure. Together, they work synergistically to improve heart function, reduce symptoms, and lower the risk of hospitalization due to heart failure.

Sacubitril + Valsartan Generic:

The generic name for the sacubitril and valsartan combination is "sacubitril/valsartan." Generic versions of this combination medication may be available under different brand names. These versions contain the same active ingredients as the brand-name medication and are approved by regulatory agencies based on their bioequivalence and safety.

Write Your Own Review
You're reviewing:Vymada Tablet (Sacubitril + Valsartan)
Your Rating

Essential Safety Advice to Follow when Using Vymada Tablet (Sacubitril + Valsartan)

  • Before taking Vymada Tablet (Sacubitril + Valsartan), patients should inform their doctor about any medical conditions they have, including allergies, kidney disease, liver disease, and heart disease.
  • Patients should also inform their doctor about any medications they are taking, including over-the-counter medications, supplements, and herbal remedies. It's important to follow the dosage instructions provided by the doctor and not exceed the recommended dose.
  • Patients taking Vymada should avoid drinking alcohol, as it may worsen the side effects of the medication. They should also avoid driving or operating heavy machinery until they know how the medication affects them.
  • Patients should inform their doctor if they experience any of the following symptoms while taking Vymada: swelling of the face, lips, tongue, or throat, difficulty breathing, hives, or any signs of an allergic reaction.

Some of the specific indications for Vymada Tablet (Sacubitril + Valsartan) include

  • Cardiovascular breakdown Treatment: Vymada Tablet is utilized to treat cardiovascular breakdown with decreased launch part (HFrEF) in grown-ups. It assists with working on the side effects of cardiovascular breakdowns, like windedness, weakness, and enlarging in the lower legs and feet.

  • Lowering Blood Pressure: Valsartan, one of the active ingredients in Vymada Tablet, is also used to lower high blood pressure (hypertension) in adults.

  • Reducing the Risk of Hospitalization: Vymada Tablet has been shown to reduce the risk of hospitalization due to heart failure in patients with HFrEF.

  • Improving Quality of Life: By improving symptoms of Heart Failure, Vymada Tablet can help improve the overall quality of life for patients with HFrEF.

  • Post-Myocardial Infarction: Vymada Tablet is also used in adult patients who have had a heart attack and have signs of heart failure or have a reduced ejection fraction.

Sacubitril + Valsartan Cost:

The cost of sacubitril and valsartan combination medication can vary depending on factors such as the brand, dosage strength, geographic location, and healthcare coverage.

Some of the Secondary Effects of Vymada Tablet (Sacubitril + Valsartan)

  • Hypotension: Vymada may cause a drop in blood pressure, which can lead to dizziness, lightheadedness, or fainting. Patients with low blood pressure or who are taking other blood pressure-lowering medications should be monitored closely while taking Vymada.
  • Hyperkalemia: Vymada may cause high levels of potassium in the blood, which can be dangerous. Symptoms of hyperkalemia may include muscle weakness, slow heart rate, and irregular heartbeat. Patients with kidney problems or who are taking other medications that increase potassium levels should be monitored closely while taking Vymada.
  • Renal Impairment: Vymada may cause or worsen kidney problems. Patients with pre-existing kidney problems should be closely monitored while taking Vymada.
  • Angioedema: Rarely, Vymada may cause a serious allergic reaction called angioedema. Symptoms may include swelling of the face, lips, tongue, or throat, difficulty breathing, and hives. Patients should seek emergency medical attention if they experience any of these symptoms.

Other common side effects may include cough, headache, diarrhea, fatigue, and back pain.

Answers to Common Inquiries About Vymada Tablet (Sacubitril + Valsartan)

Q: Could Vymada at any point be utilized alone to treat cardiovascular breakdown?

A: No, Vymada is typically endorsed in the mix with other cardiovascular breakdown drugs.

Q: How long does it require for Vymada to begin working?

A: Vymada might require a little while to begin working. Patients ought to keep accepting the prescription as endorsed, regardless of whether they feel better immediately.

Q: Might Vymada at any point cause dazedness?

A: Indeed, unsteadiness is one of the most widely recognized symptoms of Vymada. Patients ought to try not to drive or work apparatus until they know what the drug means to them.

Q: Could Vymada at any point be taken during pregnancy?

A: No, Vymada ought not to be accepted during pregnancy as it might hurt the creating hatchling.

Q: Could Vymada at any point be taken with food?

A: Vymada can be taken regardless of food. In any case, patients ought to keep away from high-fat feasts as they might diminish the retention of the drug.

Q: Is Vymada a nonexclusive medicine?

A: No, Vymada is a brand-name drug that contains two dynamic fixings, Sacubitril and Valsartan.

Significant Drug Interactions that Require Attention For Vymada Tablet (Sacubitril + Valsartan)

Vymada Tablet (Sacubitril + Valsartan) can associate with different prescriptions and substances, which can influence its adequacy or cause unfriendly impacts. Here is a portion of the medications that might interface with the Vymada Tablet:

  • ACE inhibitors: Taking a Vymada Tablet with ACE inhibitors can increase the risk of angioedema (a serious allergic reaction) and hypotension (low blood pressure).
  • Aliskiren: Concurrent use of Vymada Tablet and Aliskiren can increase the risk of kidney problems, low blood pressure, and hyperkalemia (high levels of potassium in the blood).
  • NSAIDs: Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and aspirin, can reduce the effectiveness of Valsartan and increase the risk of kidney problems.
  • Lithium: Concurrent use of Vymada Tablet and Lithium can increase the level of Lithium in the blood, leading to toxicity.
  • Diuretics: Using Vymada Tablet with diuretics can increase the risk of low blood pressure and kidney problems.
  • Potassium supplements or salt substitutes: Concurrent use of Vymada Tablet with potassium supplements or salt substitutes can increase the risk of hyperkalemia.

It is important to inform your healthcare provider about all the medications, supplements, and herbal products you are taking before starting Vymada Tablet to avoid any potential drug interactions.

More Information Demo
Manufacturer:Novartis Ltd, India
Equivalent Brand:Entresto
Generic Search:Sacubitril and Valsartan